The distinct contrasts between K18-hACE2 and PWK x K18-hACE2 mice in ISG signatures, chemokine expression, and viral dynamics prompted us to test the role of IFN-I by treating both genetic backgrounds with a single dose of anti-IFNAR neutralizing monoclonal antibody 24 h prior to infection. This evidence concerns the gene KRT18 and infection.